Statistics for Navamedic ASA (id:10464 NAVA)
Valuation metrics
Market cap
441.57M
Enterprise value
514.27M
Trailing P/E (ttm)
17.86
Forward P/E
14.79
PEG ratio
14.79
Price/Sales (ttm)
3.00
Price/Book (mrq)
1.95
Enterprise Value/Revenue
3.00
Enterprise Value/EBITDA
9.31
Overview
Shares outstanding
17.66M
Float
11.87M
Shares short
% Held by insiders
3.00%
% Held by institutions
3.00%
Average volume (10 days)
7.97K
Average volume (90 days)
Price summary
52-Week low
23.00
52-Week high
40.00
52-Week change
-44.88%
Beta
3.00
50-Day moving average
28.08
200-Day moving average
31.93
Dividends and splits
Forward annual dividend rate
3.99
Forward annual dividend yield
3.00
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
April 13, 2010
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31, 2023
Most recent quarter (mrq)
June 30, 2024
Profitability
Profit margin
3.73%
Operating margin
3.87%
Operational effectiveness
Return on assets
5.20%
Return on equity
8.14%
Income statement
Revenue (ttm)
29.64
Revenue per share (ttm)
29.64
Quarterly revenue growth (yoy)
3.00
Gross profit (ttm)
199.05M
EBITDA
55.29M
Net income to common (ttm)
19.62M
Diluted EPS (ttm)
1.40
Quarterly earnings growth (yoy)
-70.80%
Balance sheet
Total cash (mrq)
46.47M
Total cash per share (mrq)
2.68
Total debt (mrq)
126.92M
Total Debt/Equity (mrq)
48.05
Current ratio (mrq)
163.80%
Book value per share (mrq)
12.82
Cash flow
Cash flow statement
9.27M
Levered free cash flow (LFCF)
22.96M